Cargando...
Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
Ovarian cancer is the most lethal gynecologic malignancy. Surgery and chemotherapy are the primary treatments for ovarian cancer; however, patients often succumb to recurrence with chemotherapeutic resistance within several years after the initial treatment. In the past two decades, immunotherapy ha...
Gardado en:
| Publicado en: | Front Immunol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7572849/ https://ncbi.nlm.nih.gov/pubmed/33123161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.577869 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|